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Abstract: 
 
Contrary to popular belief, we report that background interference in 
conductimetric biochips can be exploited using a novel “co-detection” principle to 
significantly improve the reliability of detecting trace quantities of biomolecules. 
The technique called “co-detection” exploits the non-linear redundancy amongst 
synthetically patterned biomolecular logic circuits for deciphering the presence or 
absence of target biomolecules in a sample. In this paper, we demonstrate the “co-
detection” principle on gold-nanoparticle based conductimetric soft-logic circuits 
which uses a silver-enhancement technique for signal amplification.  Using co-
detection, we have been able to measure a 1000 times improvement in the reliability 
of detecting mouse IgG at concentration levels that are 105 lower than the 
concentration of rabbit IgG which serves as background interference.  
Description
A major challenge in the area of biosensors is to be able to detect target biomolecules in 
the presence of large background interference1. In many cases, background interference 
could simply constitute the presence of non-target analytes which could not only produce 
non-specific binding events but also cause steric hindrance, preventing binding between 
target analytes with its specific recognition probes (antibody or DNA)2. Most of the 
reported methods in biosensors either aim to reduce the effect of background interference 
using pre-filtering techniques3 or aim to boost the concentration of the target analyte 
using pre-concentration4 or target-amplification (e.g. polymerase chain reaction or PCR)5-
6.  In this paper we report that background interference created by the presence of non-
specific analytes can be exploited to amplify and improve the reliability of detection of 
the target analyte. The principle which we call “co-detection” can simply be illustrated 
using a biosensor reliability curve in Fig. 1a where analyte 1 serves as the target to be 
detected and analyte 2 serves as the background interference. Ideally, the detection error-
rate (DER) or the sum of false-positive or false-negative errors decreases with the 
increase in analyte 1 concentration (ignoring the Hook effect7)  and the DER is largely 
unaffected or increases when the concentration of analyte 2 (acting as background 
interference) increases. However in “co-detection”, addition of analyte 2 reduces the 
DER for analyte 1, as illustrated in Fig. 1a, and hence enhances the reliability of 
detection.  
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Fig. 1. (a) Illustration of “co-detection” principle, where the presence of analyte2 enhances the 
reliability of detection of analyte1; (b) architecture of an OR gate where the anti-mouse IgG and 
anti-rabbit IgG are mixed and patterned between the electrodes; (c) formation of a sandwich 
assay between the target analyte, its specific antibody and a secondary antibody conjugated with 
gold nanoparticle; (d) silver-enhancement procedure where the gold nanoparticle catalyzes the 
silver which deposits around the particle, thus increasing its size and in the process forming a 
conductive bridge between the electrodes; (e) conductance measured across the electrodes of the 
OR gate during the enhancement procedure for different logic conditions; (f) SEM image of the 
inter-electrode spacing showing the formation of the conductive bridge by silver enhanced gold 
nanoparticle; (g) architecture of an AND gate where the anti-mouse IgG and anti-rabbit IgG are 
cascaded between the electrodes; (h)&(i) formation of partial sandwich assay and conductive 
bridge due to the presence of only one of the analyte; (j) conductance measured across the 
electrodes of the AND gate during the silver-enhancement procedure under different logic 
conditions.  
 
 
Co-detection is similar in spirit to many noise exploitation techniques like stochastic 
resonance which has been reported in physics8 and biology9-10, where it has been shown 
that the addition of random noise into a non-linear system in fact improves the system 
sensitivity. However, the key towards implementing co-detection in biosensors is to 
effectively control the coupling (or interference) between different analytes and to exploit 
the non-linear response of the biosensor. In this regard, we had previously proposed a 
forward error correction (FEC) immunosensor11 platform where biomolecular soft-logic 
circuits were fabricated to synthetically produce interference between the binding events 
of multiple pathogens. In this work, we first report the fabrication of biomolecular logic 
circuits using silver enhanced nanoparticles and then use the biosensor platform to 
demonstrate the “co-detection” principle. We show that the proposed approach can 
improve the reliability of detecting target analyte (mouse IgG) by three orders of 
magnitude when the background interference (rabbit IgG concentration) is more than 105 
higher than the target analyte (mouse IgG) concentration.  
 
The architecture of the two logic functions (soft-AND and soft-OR) which has 
been used in this work is shown in Fig. 1b and Fig. 1g where antibodies corresponding to 
analyte A and B (mouse IgG and rabbit IgG) are patterned at different spatial locations 
between two gold electrodes. For the soft-OR logic gate, a mixture of goat anti-rabbit IgG 
and goat anti-mouse IgG was patterned as shown in Fig. 1b, where as for the soft-AND 
gate, the antibodies were patterned in a cascaded fashion as shown in Fig. 1g 
(Supplementary Fig. 1). 
When the analyte is applied to the immobilized biochips, the target biomolecules 
(mouse and rabbit IgG) hybridize with their specific antibodies. The secondary antibodies 
conjugated with gold (Au) nanoparticles are then applied to the biochip, which leads to 
the formation of a sandwich assay as shown in Fig. 1c. In this stage, the current measured 
between the electrodes (for a fixed potential difference) is small. The next step involves a 
silver enhancement technique to amplify the hybridization events into a measurable 
electrical signal. The sandwich assay is exposed to a solution of Ag(I) and hydroquinone 
(photographic developing solution). The gold nanoparticles act as a catalyst and reduce 
silver ions into metallic silver in the presence of a reducing agent (hydroquinone). The 
reduced silver then deposits on the gold surface, thus enlarging the size of the gold 
nanoparticles as shown in Fig. 1d. As the size of the silver islands grows, they provide 
shorter paths for electrons to hop between the electrodes. With the increase in 
enhancement time (the time of the exposure with the silver enhancer solution), the 
consistent growth of silver-enhanced particles completely bridges the area between the 
electrodes (shown in Fig. 1d). Even though, silver-enhancement technique has been used 
for conductometric DNA arrays and immunoasssays13-17, it has not been yet extended to 
implement logic-functions as is reported in this work.  In the case of the soft-OR gate the 
conductive bridge between the electrodes is formed when either one of the analytes 
(rabbit IgG or mouse IgG) is present in the sample, assuming that the density of antibody 
probes is large enough. This scenario is shown in Fig. 1d for the case when both rabbit 
IgG and mouse IgG are present in the sample and Fig. 1f shows an SEM verification of 
the bridge formation between the two electrodes. Fig. 1e shows the measured 
conductance across the electrodes during the process of silver enhancement under 
different logic conditions (control, only mouse IgG present, only rabbit IgG present and 
both mouse and rabbit IgG present). The figure shows that indeed compared to the 
control experiment, the conductance change is significantly large for all the logic 
conditions and increases with increase in enhancement time.  
In the case of ideal AND gate (shown in Fig. 1g), the bridge across the electrode 
will be completely formed only when both of biomolecules (rabbit IgG and mouse IgG) 
are present. However, for a soft-AND gate, the bridge can be partially formed (shown in 
Fig. 1h and Fig. 1i) when only one of the analytes is present. This leads a smaller 
conductance change compared to the completely formed bridge. Fig. 1j shows the 
conductance measured across the electrodes of the AND gate under different logic 
conditions (control, only one analyte present and both analyte present). The result shows 
that the change in conductance is the largest when both of biomolecules are present as 
compared to the condition when only one of the biomolecule is present, thus verifying the 
soft-AND logic function. Also, similar to the OR gate response, the conductance 
increases with increase in enhancement time.  
We have also verified that the responses of the fabricated soft-AND and soft-OR gates 
are consistent across different concentrations of the input analytes. Fig. 2a and Fig. 2b 
show the conductance measured across both the gates for different concentrations of 
analytes and under different logic conditions. For this experiment, the rabbit IgG and 
mouse IgG were serially diluted using PBS to prepare 100-fold dilutions representing IgG 
concentrations ranging from 12 μg/mL-0.12 ng/mL. Each of the tests was repeated three 
times and the results were measured every 3 minutes after the replacement of new silver 
enhancer solution onto biochips. “Control” experiments for all the experiments were 
obtained using bovine IgG. It can be seen from Fig. 2a and Fig. 2b that under different 
concentration levels of analytes the response of the logic function remains consistent, 
however, the magnitude of the measured conductance scales log-linearly with 
concentration.  The measured data was then used to estimate the parameters of a two-
dimensional coupled log-linear model18, one for each of the logic gates as shown in Fig.
2e and Fig. 2f (Supplementary Fig. 3 and Supplementary Table 1). Also included in 
the set of models were single analyte biochips whose measured conductance was only 
dependent on the concentration of a single analyte (experimental results shown in Fig. 2c 
and Fig. 2d). The responses of the single analyte biochips are shown in Fig. 2g and Fig.
2h which are one-dimensional log-linear models.  
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Fig. 2. Experimental results showing the measured conductance from (a) a soft-OR logic 
gate for different concentration levels of rabbit and mouse IgG; (b) a soft-AND logic gate 
for different concentration levels of rabbit and mouse IgG; (c) a mouse IgG specific 
biochip for different concentration levels of mouse IgG; (d) a rabbit IgG specific biochip 
for different concentration levels of rabbit IgG; coupled log-linear models determined 
using experimental data for (e) soft-OR logic-gate; (f) soft-AND logic-gate; (g) mouse 
IgG biochip; (h) rabbit IgG biochip; (i) architecture of the Bayesian decoder used to 
compute the posterior probability of the presence of mouse IgG given an array of 
conductance measurements.  
To demonstrate the “co-detection’’ principle, a total of six different biochips were 
used: two single analyte biochip specific to mouse IgG, two single analyte biochips 
specific to rabbit IgG, one soft-AND biochip and one soft-OR biochip. The experimental 
procedure involved the following steps: (a) an unknown sample (containing different 
concentration of mouse and rabbit IgG) were applied to the six biochips; (b) the measured 
conductance Xi were presented as inputs to the biosensor model, whose outputs were 
normalized to generate posterior probabilities. For example, the soft-OR biochip model 
(Fig. 2a) generated the posterior probability P(IgGM + IgGR|Xi) that either one of the 
analytes (rabbit or mouse IgG) is present given the conductance measurement Xi. As 
shown in Fig. 2i, all the posterior probabilities are combined together using Bayesian 
techniques to compute the probability of presence of target analytes P(IgGM|X1,.,X6), 
P(IgGR|X1,..,X6) given all the measured conductances X1,..,X6 (from six biochips) (The 
decoder is described in Supplementary Fig. 4-5) The probability scores are compared 
against a pre-determined threshold to make a positive identification of the target analyte. 
Fig. 3a-b shows the detection error rate (false positive error and false negative error) 
curves that were obtained by Monte-Carlo simulations using the biochip behavioral 
models. For this experiment, the magnitude of noise was estimated from the 
experimentally determined error bars as shown in Fig. 2a-d. In Fig. 3a, the concentration 
of rabbit IgG is increased which as expected leads to the decrease in its DER. However, 
the increase in concentration of mouse IgG also leads to the decrease in DER, clearly 
indicating the “co-detection” principle. A similar behavior was also observed for the 
DER of mouse IgG as shown in Fig. 3b. For comparison purposes, Fig. 3c shows the 
DER curves that were obtained if six independent rabbit and mouse IgG biochips are 
used for detection. This scenario replicates the testing strategy commonly employed in 
diagnostics where repeated experiments followed by majority voting are performed to 
obtain reliable detection results. The plots in Fig. 3c clearly show the absence of “co-
detection” which is expected as there is very little coupling between different detection 
tests. 
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Fig. 3. Demonstration of “co-detection” principle based on mouse IgG experiments and 
behavioral simulations. Detection error-rate (DER) curves obtained using behavioral 
models in Fig. 2 for different concentration of rabbit and mouse IgG: (a) showing co-
detection when presence of higher concentration of mouse IgG enhances the detection 
reliability of rabbit IgG. M1 represents mouse IgG concentration: 1 ng/mL; M2 
represents mouse IgG concentration: 100 ng/mL; M3 represents mouse IgG 
concentration: 10 ug/mL; M4 represents mouse IgG concentration: 1 mg/mL. (b) 
presence of higher concentration of rabbit IgG enhances the detection reliability of 
mouse IgG; R1-R4 hold similar meaning and same value as M1-M4. (c) absence of co-
detection in the conventional repetitive tests where rabbit IgG does not affect the 
detection reliability of mouse IgG; Experimental verification of co-detection: (d) results 
from a mouse IgG biochip when 100pg/ml mouse IgG is used; (e) results from a mouse 
IgG biochip when 100pg/ml mouse IgG is used in presence of 10g/ml of rabbit IgG; (f) 
results from the Bayesian decoder showing significant improvement in reliability of 
mouse IgG detection in the presence of background rabbit IgG. 
 
We now report results where the “co-detection” principle has been experimentally 
verified in the detection of mouse IgG. For the experiment, 100 pg/mL mouse IgG is 
added to the solution of 10 ug/mL rabbit IgG which serves as the background interference. 
10 μg/mL bovine IgG is used as negative control experiment. For calibration purposes, 
we first applied a sample containing only 100 pg/mL mouse IgG to a single mouse IgG 
biochip. Fig. 3d shows the detection result compared against the negative control. Even 
though the experiments show that on average the silver-enhancement technique can 
detect the trace quantity of mouse IgG, the variance of the experiment (shown by the 
overlap between the error bars) is too large for reliable confirmation. Fig. 3e shows the 
result obtained from the single analyte biochip when a mixture of 100 pg/mL mouse IgG 
and 10 μg/mL rabbit IgG is applied. As expected, the results show similar response as the 
previous experiment since anti-mouse IgG are non-specific to rabbit IgG. In the last set of 
experiment, the mixture with similar composition was applied to the six biochips and the 
measured conductances were process by the decoding algorithm. Fig. 3f shows the 
response obtained from the decoder and compares it with results obtained for the negative 
control experiments. Note that the output of the decoder is the normalized score 
indicating the presence or absence of mouse IgG. It can be clearly seen that not only has 
the magnitude of the scores have increased significantly compared to the control, the 
variance of the results have also decreased by orders of magnitude. Since there is no 
overlap between error bars, perfect detection of mouse IgG can be achieved in the 
presence of high background concentration of rabbit IgG. We believe that the non-linear 
response of the FEC biochip in conjunction with “co-detection” is the primary reason 
behind the improvement in reliability. The presence of large background interferences 
introduces conduction sites which can be easily populated by the target analytes. The 
computational approach for co-detection bears similarity to DNA signature discovery 
techniques19. However, the key difference in this work is exploitation of background 
noise instead of suppressing it. We would also like to point out that even though in our 
report, we have used only two analytes (mouse IgG and rabbit IgG) to demonstrate the 
“co-detection” principle, the approach is generic and can be extended to any kinds and 
any number of analytes. In fact we anticipate significant improvements in reliability as 
the number of analytes increases. This is because of the exponential increase in the side-
information that is available through coupling between multiple binding events. One of 
the key applications where “co-detection” could be used in the future is in the early 
diagnosis of HIV.  Early diagnosis of HIV requires detecting trace quantity of HIV 
biomolecules that are usually accompanied by other non-specific biomolecules that 
directly interfere in the detection process20 and hence require a long-time for 
confirmation tests. The improvement in reliability offered by “co-detection” will reduce 
the window period for positive or negative diagnosis and hence can facilitate rapid 
screening.  
 
Methods 
Biochip fabrication 
The following procedure was used for fabricating the silver-enhanced gold nanoparticle 
based biochip and then immobilizing specific antibodies onto the substrate. The biochips 
were fabricated from 400 silicon wafers (p-type 100, thickness 500-550 m). A 2 m 
thick layer of thermal oxide was grown over the silicon to serve as an insulator between 
the electrodes and the substrate. Photolithography was used to pattern photo-resist (PR) 
followed by deposition of metal electrodes through evaporation of 10nm of chrome under 
100 nm of gold and the formation of an interdigitated electrode array (IEA) using a lift-
off process.  
Biochip surface functionalization  
The surface of biochips was then modified for immobilizing the antibody. The chips were 
first immersed in acetone in a crystallizing dish for 10 min to dissolve away the 
protective PR layer. The chips were then treated with 1:1 mixture of concentrated 
methanol and hydrochloric acid for 30 min followed by immersion into boiling distilled 
water for 30 min. The biochips were allowed to air dry completely. The biochips were 
then silanized in an anaerobic glove box. The biochips were immersed in a crystallizing 
dish containing a solution of 2% 3-Mercaptopropytrimethyloxysilane (MTS) (Sigma; 
St.Louis, MS) for 2 h. The chips were then rinsed in toluene and were allowed to dry 
completely. After silanization, N-y-maleimidobutyryloxy succinimide ester (GMBS) 
(Sigma; St.Louis, MA) was chosen as crosslinkers to avoid formation of multi-protein 
complex. The crosslinking reagent was dissolved in a minimum amount of 
dimethylformamide (DMF) and then diluted with ethanol to a final concentration of 2 
mM. The silanized substrate was treated with crosslinker for 1 hour and washed in 
phosphate buffered saline (PBS, pH 7.4). After the application of the crosslinker, 
antibody (Sigma; St.Louis, MA) was immobilized onto the biochip active surface. The 
biochips were placed in a petri dish, sealed with parafilm and allowed to incubate at 37oC 
for 1 h. The biochips were then treated with 2 mg/mL bovine serum albumin (BSA) 
(Sigma; St.Louis, MA) for 45 min. After incubation, the biochip surface was rinsed with 
PBS (pH 7.4) and was allowed to air dry (summarized in Supplementary Fig.2).  
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